cagrilintide semaglutide Semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist, has well-established weight-loss benefits. Cagrilintide, a long-acting analogue of the satiety hormone amylin, has shown promise for weight loss in early trials. The potential benefit Cagrilintide–semaglutide (CagriSema) as an add-on

10.1038/nprot.2012.153 25 JafarpourZ.SoleimaniM.HosseinkhaniS.MH

Because of its ability to increase intestinal permeability, functional screening of Zot protein was conducted, leading to the discovery of a human intestinal Zot analogue, zonulin, which, like Zot, has been shown to reduce TEER of intestinal tissue (7)

Cold-Chain Logistics Temperature-sensitive compounds are packed with insulated cold-chain materials and dispatched same-day

doi: 10.1371/journal.pone.0019597

Somnogenic Activity & Delta-Wave EEG Regulation: Investigating how the neuropeptide modulates slow-wave (delta) sleep patterns and brain spindles in animal models